Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

October 09, 2015 1:49 PM ET


Company Overview of Cocrystal Pharma, Inc.

Company Overview

Cocrystal Pharma, Inc., a preclinical-stage biopharmaceutical company, intends to develop medicines for use in treating human viral diseases. The company focuses on developing inhibitors that viral replication enzymes and viral replication protein. It is developing antiviral therapeutics for human diseases, including Hepatitis C virus, Influenza virus, and Norovirus. The company also develops targeted in-house chemical libraries consisting of antiviral compounds of nucleosides, non-nucleoside inhibitors, metal-binding inhibitors, and fragments. In addition, it is developing compounds that inhibit HCV helicase, an enzyme that is essential for hepatitis C viral replication. The company was fou...

19805 North Creek Parkway

Bothell, WA 98011

United States

Founded in 2007

22 Employees



Key Executives for Cocrystal Pharma, Inc.

Co-Founder and President
Age: 55
Total Annual Compensation: $180.0K
Co-Founder, Vice Chairman, Senior Advisor and Member of Scientific Review Committee
Age: 68
Total Annual Compensation: $250.0K
Chief Financial Officer , Principal Accounting Officer and Treasurer
Age: 68
Total Annual Compensation: $150.0K
Compensation as of Fiscal Year 2014.

Cocrystal Pharma, Inc. Key Developments

Cocrystal Pharma, Inc Appoints Douglas Mayers as Chief Medical Officer

Cocrystal Pharma, Inc. announced the appointment of Douglas Mayers, M.D., to the position of chief medical officer (CMO). Dr. Mayers is a specialist in infectious diseases and has nearly 27 years of medical and clinical development experience spanning all phases of global clinical research & development and commercialization. Most recently, Dr. Mayers spent the past year at the United States Army Medical Research Institute of Infectious Diseases working with colleagues to discover and develop drugs against the Ebola virus.

Cocrystal Pharma, Inc. Appoints Jeffrey Meckler as Chief Executive Officer, Effective from October 1, 2015

Cocrystal Pharma, Inc. announced that its Board of Directors has appointed board member Jeffrey Meckler to the position of Chief Executive Officer (CEO), effective October 1, 2015. Mr. Meckler had been serving as company's Interim CEO since March 31, 2015. Mr. Meckler has over 25 years of experience in life science companies, including 17 years at Pfizer Inc. in a variety of positions, including Manufacturing, Systems, Market Research and Corporate Finance. Mr. Meckler currently serves as the Chairman of the Board for Retrophin, Inc. Mr. Meckler has also served as Managing Director of The Andra Group.

Cocrystal Pharma, Inc. Names Walt Addison Linscott, Esq. as General Counsel and Corporate Secretary

Cocrystal Pharma, Inc. announced the appointment of Walt Addison Linscott, Esq. as General Counsel and Corporate Secretary. Most recently, Linscott served as Global Strategic Legal Advisor for Thompson Hine, LLP. Linscott's experience as a lawyer spans 25 years and includes serving as General Counsel and Corporate Secretary of Carestream Health, Inc., leading as Chair of the Life Sciences practice and office managing partner of an international law firm and serving as the Vice President, General Counsel and Corporate Secretary of a branded pharmaceutical company that was sold to Abbott Laboratories.

Similar Private Companies By Industry

Company Name Region
Bioponic Phytoceuticals, Inc. United States
Advanced Immuni T Inc. United States
River's Edge Pharmaceuticals LLC United States
Redwood Scientific Technologies, Inc. United States
Atreaon, Inc. United States

Recent Private Companies Transactions

Private Placement
March 17, 2015
November 25, 2014
RFS Pharma, LLC

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Cocrystal Pharma, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at